ArticleInternational journal of women's health2025
Global, Regional, and National Burden and Trends of Female Cancers Among the Elderly Women (≥60 Years Old): An Analysis Based on the 2021 Global Burden of Disease Study.
Article in International journal of women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Global Burden of Ovarian Cancer and Causal Risk Factors from 1990 to 2021: An Integrated GBD and Mendelian Randomization Analysis.International journal of women's health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aims to provide a comprehensive assessment of the global cancer burden among women aged 60 and older from 1990 to 2021, focusing specifically on breast cancer (BC), cervical cancer (CC), ovarian cancer (OC), and uterine cancer (UC). Methods: Utilizing the 2021 Global Burden of Disease (GBD) data, the study analyzes the incidence, prevalence, mortality, and disability-adjusted life years (DALYs) associated with these cancers. Joinpoint regression is employed for trend analysis and to calculate the average annual percentage change (AAPC), while the age-period-cohort (APC) model is used to explore the effects of age, period, and birth cohort on disease indicators. Results: In 2021, an estimated 721,111 deaths from female cancers were reported globally among the elderly women, with BC remaining the malignant tumor linked to the highest mortality rate. Nations characterized by a high Socio-Demographic Index (SDI) generally displayed increased Age-Standardized Incidence Rates (ASIR) and Age-Standardized Prevalence Rates (ASPR). Conversely, the Age-Standardized Rates (ASR) of DALYs and Age-Standardized Death Rates (ASDR) revealed opposite trends. In addition, Both ASIR and ASPR for BC and UC have demonstrated a rising trajectory, while the ASR pertaining to DALYs and mortality associated with the four cancers has shown a declining pattern. Conclusion: The disease burden of female cancers among elderly women remains substantial and is anticipated to escalate, revealing significant disparities across various regions and populations. This study underscores the necessity for more effective and targeted interventions to tackle this evolving health challenge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.